跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 玉惠
副教授
,
學士後護理學系
https://orcid.org/0000-0002-8382-9820
電子郵件
gracelin
tmu.edu
tw
h-index
116
引文
6
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2015
2025
每年研究成果
概覽
指紋
網路
專案
(7)
研究成果
(20)
資料集
(3)
類似的個人檔案
(6)
指紋
查看啟用 Yu-Huei Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Chronic Obstructive Pulmonary Disease
65%
Gastroesophageal Reflux
49%
Meta-Analysis
49%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
35%
Randomized Controlled Trial
34%
Systematic Review
32%
Angiogenesis
32%
Quality of Life
32%
Exercise
32%
Symptom
29%
Breast Cancer
16%
Intensive Care Unit
16%
Combination Therapy
16%
Leukopenia
16%
Chest Wall Oscillation
16%
Auriculotherapy
16%
Thiazolidinedione
16%
Sequential Analysis
16%
Epidermal Growth Factor Receptor
16%
Endurance Training
16%
Artificial Respiration
16%
Cohort Analysis
16%
Case-Control Study
16%
Cholesterol Synthesis
16%
Noninvasive Positive Pressure Ventilation
16%
Injury
16%
Bladder Cancer
16%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
16%
Farnesoid X Receptor
16%
Liver Cirrhosis
16%
Lung Adenocarcinoma
12%
Noninvasive Ventilation
10%
Gefitinib
10%
Sputum
9%
Bevacizumab
8%
Leukocyte
7%
Braden Scale
7%
Transitional Cell Carcinoma
7%
Body Mass Index
6%
Maturity Onset Diabetes of the Young
5%
Nursing and Health Professions
Obstructive Lung Disease
49%
Meta Analysis
49%
Gastroesophageal Reflux
32%
Systematic Review
32%
Quality of Life
32%
Intensive Care Unit
28%
Sequential Analysis
16%
Auriculotherapy
16%
Chest Wall Oscillation
16%
Adverse Event
16%
Cross-Sectional Study
16%
Hydrocortisone
16%
Breast Cancer
16%
Self Care
16%
Case-Control Study
16%
Continuous Positive Airway Pressure
16%
Artificial Respiration
16%
Cohort Analysis
16%
Pressure Injury
16%
Symptom
16%
Patient Care
16%
Leukopenia
16%
Liver Cirrhosis
16%
Body Composition
16%
Longitudinal Analysis
16%
Intensive Care
16%
Baccalaureate Nursing Student
16%
Emergency Care
16%
Noninvasive Ventilation
10%
Hospitalization
8%
Braden Scale
7%
Body Mass
6%
Walking Distance
6%
Fat Mass
6%
Albumin Level
5%
Aspiration Pneumonia
5%
Digestive System Ulcer
5%
Embase
5%
Medline
5%
CINAHL
5%
Checklist
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Gastroesophageal Reflux
65%
Cohort Study
32%
Farnesoid X Receptor
32%
Symptom
31%
Statin (Protein)
18%
Lung Cancer
18%
Randomized Controlled Trial
18%
Chemotherapy
16%
Breast Cancer
16%
Thiazolidinedione
16%
Ischemia
16%
Bronchodilating Agent
16%
Adrenergic Receptor Stimulating Agent
16%
Hydroxymethylglutaryl Coenzyme A Reductase Kinase
16%
Bladder Cancer
16%
Auriculotherapy
16%
Leukopenia
16%
Epidermal Growth Factor Receptor
16%
Combination Therapy
16%
Lung Adenocarcinoma
13%
Gefitinib
9%
Bevacizumab
7%
Transitional Cell Carcinoma
7%
Bile Acid
6%
Sterol Regulatory Element Binding Protein 2
6%
Non Insulin Dependent Diabetes Mellitus
5%
Atorvastatin
5%
